Related Experiment Video
Updated: Feb 2, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Double Graph Attention Network for predicting non-alcoholic fatty liver disease in patients with type 2 diabetes
Tianbin Chen1, Yongbin Zeng1, Jinlin Wang1
1Department of Laboratory Medicine, Gene Diagnosis Research Center, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Laboratory Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Abstract:
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease, while non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, which can progress to more severe liver diseases such as liver fibrosis, cirrhosis and hepatocellular carcinoma. Approximately 50%-70% of T2DM patients also have NAFLD. Traditional diagnostic methods like liver biopsy have limitations, making large-scale screening difficult. In the past decade, machine learning have emerged as crucial tools for assisting in NAFLD diagnosis. In this paper, we propose a novel Dual Graph Attention Network (DGAN) for diagnosing NAFLD in T2DM patients. We model the NAFLD diagnosis problem as a node classification task on graph by using features similarity constructed graph. The model includes a Feature Attention Module to capture feature importance through a feature graph and a Patient Attention Module to evaluate patient importance using graph attention mechanisms. These components enhance the model's classification accuracy by leveraging both feature and topological information. The model was trained and tested on clinical data from 2402 T2DM patients, demonstrating superior accuracy in identifying NAFLD compared to other models.
More Related Videos
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Predicting Molecular Geometry